All Stories

  1. Human in Vitro ADMET and Prediction of Human Pharmacokinetics and Toxicity Liabilities at the Discovery Stage
  2. Optimizing the use of CROs by academia and small companies
  3. ADME (Absorption, Distribution, Metabolism, Excretion): The Real Meaning—Avoiding Disaster and Maintaining Efficacy for Preclinical Candidates
  4. De-Risking Drug Discovery Programmes Early with ADMET
  5. Safety of medicine and the use of animals in research
  6. Filtering toxicity from the pipeline: The role of high content toxicology in early identification of toxic liabilities
  7. VC Firms Must Change Early-Stage Investment Strategies
  8. QSAR-based permeability model for drug-like compounds
  9. ADMET for Medicinal Chemists
  10. Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates
  11. Vitamin K-dependent Proteins in the Developing and Aging Nervous System
  12. ADDME – Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective
  13. Novel growth factor Gas6, phosphatidylserine and their age-related changes in the rat brain
  14. Novel growth factor Gas6, phosphatidylserine and their age-related changes in the rat brain